Thrive Wealth Management, LLC

SEC CIK: 0001847610
Latest filing: Jul 7, 2026

SEC filings (opens in a new tab)

CRSP holding history

CRISPR Therapeutics AG in every 13F filed by Thrive Wealth Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRSP overview All 13F holders of CRSP Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of CRSP by Thrive Wealth Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−3,100−100.0%	Sold out	Holders
Q3 2025	3,100	$200.9K	<0.1%	+3,100	New	Holders
Q2 2024	0	$0	0.0%	−3,100−100.0%	Sold out	Holders
Q1 2024	3,100	$211.3K	<0.1%	+3,100	New	Holders